Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W B Forman

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
American Journal of Hematology|January 1, 1980
Granulocytopenia with marked lymphocytosis manifesting Sjogren syndromeJ Goske, A D Askari, E Dickman, et al.
Blood|March 1, 1977
Techniques for demonstration of the specificity of circulating anticoagulants against antihemophilic factor (factor VIII), with studies of two cases possibly related to diphenylhydantoin therapyM C Poon, H Saito, O D Ratnoff, et al.
Annals of Ophthalmology|November 1, 1982
Periorbital ecchymoses as the initial sign in multiple myelomaH Loo, W B Forman, M R Levine, et al.
Palliative Medicine|January 1, 1993
A novel morphine sulphate preparation: clinical trial of a controlled-release morphine suspension in cancer painW B Forman, R K Portenoy, R H Yanagihara, et al.
Gerontology|January 1, 1994
Transdermal fentanyl disposition in elderly subjectsM T Holdsworth, W B Forman, T A Killilea, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1992
Influence of age, performance status, body weight, and tumor type in individuals with cancer on the disposition of warfarin and its enantiomers: Department of Veterans Affairs cooperative study number 75W B Forman, C E Cook, L R Zacharski, et al.
Cancer|August 1, 1979
Rationale and experimental design for the VA Cooperative Study of Anticoagulation (Warfarin) in the Treatment of CancerL R Zacharski, W G Henderson, F R Rickles, et al.
American Journal of Clinical Oncology|December 1, 1982
Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancerL R Zacharski, F R Rickles, W G Henderson, et al.
Journal of Medicine|January 1, 1985
Bleeding complications from warfarin anticoagulation in patients with malignancyL R Zacharski, W G Henderson, W B Forman, et al.
American Journal of Clinical Oncology|April 1, 1984
Accrual of patients into a multihospital cancer clinical trial and its implications on planning future studiesJ F Martin, W G Henderson, L R Zacharski, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
American Journal of Hematology|January 1, 1980
Granulocytopenia with marked lymphocytosis manifesting Sjogren syndromeJ Goske, A D Askari, E Dickman, et al.
Blood|March 1, 1977
Techniques for demonstration of the specificity of circulating anticoagulants against antihemophilic factor (factor VIII), with studies of two cases possibly related to diphenylhydantoin therapyM C Poon, H Saito, O D Ratnoff, et al.
Annals of Ophthalmology|November 1, 1982
Periorbital ecchymoses as the initial sign in multiple myelomaH Loo, W B Forman, M R Levine, et al.
Palliative Medicine|January 1, 1993
A novel morphine sulphate preparation: clinical trial of a controlled-release morphine suspension in cancer painW B Forman, R K Portenoy, R H Yanagihara, et al.
Gerontology|January 1, 1994
Transdermal fentanyl disposition in elderly subjectsM T Holdsworth, W B Forman, T A Killilea, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1992
Influence of age, performance status, body weight, and tumor type in individuals with cancer on the disposition of warfarin and its enantiomers: Department of Veterans Affairs cooperative study number 75W B Forman, C E Cook, L R Zacharski, et al.
Cancer|August 1, 1979
Rationale and experimental design for the VA Cooperative Study of Anticoagulation (Warfarin) in the Treatment of CancerL R Zacharski, W G Henderson, F R Rickles, et al.
American Journal of Clinical Oncology|December 1, 1982
Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancerL R Zacharski, F R Rickles, W G Henderson, et al.
Journal of Medicine|January 1, 1985
Bleeding complications from warfarin anticoagulation in patients with malignancyL R Zacharski, W G Henderson, W B Forman, et al.
American Journal of Clinical Oncology|April 1, 1984
Accrual of patients into a multihospital cancer clinical trial and its implications on planning future studiesJ F Martin, W G Henderson, L R Zacharski, et al.
Pageof 5